The choice of calcineurin inhibitor does not influence centrilobular necrosis after orthotopic liver transplantation

被引：5
|
作者：
Hassoun, Z [1 ]
Shah, V
Petrovic, LM
机构：
[1] Mayo Clin, Dept Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Anat Pathol, Rochester, MN 55905 USA
来源：
TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 05期
关键词：
D O I：
10.1016/S0041-1345(02)02955-X
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1519 / 1520
页数：2
相关论文
共 50 条
  • [21] Microproteinuria for detecting calcineurin inhibitor-related nephrotoxicity after liver transplantation
    Wan Y Lau
    World Journal of Gastroenterology, 2009, 15 (23) : 2913 - 2917
  • [22] Longterm calcineurin inhibitor therapy and brain function in patients after liver transplantation
    Pflugrad, Henning
    Schrader, Anna-Kristina
    Tryc, Anita Blanka
    Ding, Xiaoqi
    Lanfermann, Heinrich
    Jaeckel, Elmar
    Schrem, Harald
    Beneke, Jan
    Barg-Hock, Hannelore
    Klempnauer, Juergen
    Weissenborn, Karin
    LIVER TRANSPLANTATION, 2018, 24 (01) : 56 - 66
  • [23] Microproteinuria for detecting calcineurin inhibitor-related nephrotoxicity after liver transplantation
    Li, Jing
    Liu, Bin
    Yan, Lu-Nan
    Wang, Lan-Lan
    Lau, Wan Y.
    Li, Bo
    Wang, Wen-Tao
    Xu, Ming-Qing
    Yang, Jia-Yin
    Li, Fu-Gui
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (23) : 2913 - 2917
  • [24] Donor age predicts calcineurin inhibitor induced neurotoxicity after liver transplantation
    Sandri, Giovanni Battista Levi
    Giannelli, Valerio
    Ettorre, Giuseppe Maria
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
  • [25] Donor Age Predicts Calcineurin Inhibitor Induced Neurotoxicity After Liver Transplantation
    Lue, Alberto
    Martinez, Elena
    Navarro, Mercedes
    Laredo, Viviana
    Lorente, Sara
    Jose Araiz, Juan
    Agustin Garcia-Gil, Francisco
    Trinidad Serrano, Maria
    TRANSPLANTATION, 2019, 103 (08) : E211 - E215
  • [26] Influence of the Type of Calcineurin Inhibitor on HCV Recurrence after Liver Transplantation. Results of a Prospective Randomized Study
    Llado, Laura
    Fabregat, Joan
    Baliellas, Carme
    Ramos, Emilio
    Torras, Jaume
    Secanella, Lluis
    Castellote, Jose
    Rota, Rosa
    Busquets, Juli
    Pelaez, Nuria
    Xiol, Xavier
    Serrano, Teresa
    Rafecas, Antoni
    LIVER TRANSPLANTATION, 2014, 20 : S332 - S332
  • [27] Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor
    Duvoux, Christophe
    Firpi, Roberto
    Grazi, Gian L.
    Levy, Gary
    Renner, Eberhard
    Villamil, Federico
    TRANSPLANT INTERNATIONAL, 2013, 26 (04) : 358 - 372
  • [28] Choice of calcineurin-inhibitor may influence the development of de novo immune hepatitis associated with anti-GSTT1 antibodies after liver transplantation
    Aguilera, Isabel
    Manuel Sousa, Jose
    Manuel Praena, Juan
    Angel Bravo, Miguel
    Nunez-Roldan, Antonio
    TISSUE ANTIGENS, 2010, 75 (05): : 598 - 598
  • [29] Acute Esophageal Necrosis Following Orthotopic Liver Transplantation
    Planchard, Jeffrey A.
    Dikstein, Anna F.
    Koveleskie, Joseph
    Cohen, Ari
    Gurvits, Grigoriy E.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (02)
  • [30] Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation?
    Guckelberger, O
    Langrehr, JM
    Bechstein, WO
    Neuhaus, R
    Luesebrink, R
    Lemmens, HP
    Kratschmer, B
    Jonas, S
    Knoop, M
    Neuhaus, P
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (06) : 3173 - 3174
12345